| PD | Parkinson’s disease |
| AD | Alzheimer’s disease |
| ATP | Adenosine triphosphate |
| ATP synthase | Adenosine triphosphate synthase |
| BBB | Blood–brain barrier |
| CI | Complex I |
| CIII | Complex III |
| LB | Lewy’s bodies |
| COMT | Catechol O-methyltransferase |
| DpA | Dopamine |
| ND | Neurodegenerative disease |
| DNA | Deoxyribonucleic acid |
| DOPAC | 3,4-dihydroxyphenylacetic acid |
| DOPAL | 3,4-dihydroxyphenylacetaldehyde |
| FAD | Flavine-adenine dinucleotide |
| ROS | Reactive oxygen species |
| OS | Oxidative stress |
| RNS | Reactive nitrogen species |
| GSH | Glutathione |
| LAS | Lysosomal autophagic system |
| LDH | Lactate dehydrogenase |
| CSF | Cerebrospinal fluid |
| MAO | Monoamine oxidase |
| MnSOD | Manganese superoxide dismutase |
| MPTP | 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine |
| NM | Neuromelanin |
| NMDA | N-methyl-D-aspartate |
| NO | Nitric oxide |
| PTP | Permeability transition pore |
| SN | Substantia nigra |
| CNS | Central nervous system |
| SAR | Structure-activity relationship |
| GABA | Gamma-aminobutyric |
| AChEs | Acetylcholinesterases |
| α-SYN | α-synuclein |